Zimbabwe has turned down a substantial American healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' demand for sensitive biological samples.
This move was revealed following a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government representative later explained that the United States was seeking genetic material for scientific study and commercial purposes but was unwilling to share the benefits from any future medical innovations.
"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for more talks to find a deal suitable to all parties so the country's vital HIV treatment initiative can proceed.
Wider Implications
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court suspended a similar deal with the US following legal challenges were raised about the safety of Kenyans' health data.
Since resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and responsibility.
As per statements, 16 African countries have so far signed these new health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," he stated.
"Put simply, our country would provide the basic resources for medical research without any assurance that the resulting innovations would be accessible to our population should a future pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining systems already set up through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This framework is designed to guarantee that when a country provides its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to create them."
These objections over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage further dialogue with our US partners on how subsequent co-operation could be arranged in a manner that respects the independence and interests of each country."
Medical Community Response
A leading public health body expressed it understood the official position, but suggested that talks should continue considering a large portion of the country's Aids initiatives relied on foreign aid.
"Where technical issues exist, including those relating to data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.
The situation underscores the continuing debate between accepting vital foreign assistance and protecting a country's data in an ever more interconnected world.